![Christine Cvijic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Cvijic
Financieel Directeur/CFO bij
Neurogene, Inc.
Vermogen: 2 M $ op 31-05-2026
Profiel
Christine Mikail Cvijic was the founder of Neumentum, Inc., established in 2017, where the title held was Director.
Current jobs include President & Chief Financial Officer at Neurogene OpCo. since 2019,.
and President, Chief Financial Officer & Director at Neurogene, Inc. starting in 2023.
Former jobs include Independent Non-Executive Director at Advanced Accelerator Applications SA from 2017 to 2018; Senior Vice President-Corporate Development at Savient Pharmaceuticals, Inc. from 2011 to 2012; Secretary, Vice President & General Counsel at ImClone LLC from 2008 to 2011; Secretary, SVP-Legal Affairs & General Counsel at NPS Pharmaceuticals, Inc. from 2014 to 2015; Secretary & Executive VP-Corporate Development at Dendreon Corp.; and Chief Administrative Officer & General Counsel at Sio Gene Therapies, Inc. from 2015 to 2017.
Education includes undergraduate studies at Rutgers State University of New Jersey and graduate studies at Fordham University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,54% | 07-07-2026 | 84.040 ( 0,54% ) | 2 M $ | 31-05-2026 |
Actieve functies van Christine Cvijic
| Bedrijven | Functie | Begin |
|---|---|---|
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Financieel Directeur/CFO | 24-09-2019 |
Eerdere bekende functies van Christine Cvijic
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Directeur/Bestuurslid | 01-03-2018 |
| SIO GENE THERAPIES INC. | Hoofd Administratief Officier | 01-03-2017 |
| NPS PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-02-2015 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 02-02-2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Algemeen Adviseur | 01-02-2011 |
Opleiding van Christine Cvijic
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
Fordham University School of Law
 Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Neumentum, Inc.
 Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Health Technology |
Kies MarketScreener 
